SK103797A3 - Mixture of compounds and pharmaceutical composition containing the same - Google Patents

Mixture of compounds and pharmaceutical composition containing the same Download PDF

Info

Publication number
SK103797A3
SK103797A3 SK1037-97A SK103797A SK103797A3 SK 103797 A3 SK103797 A3 SK 103797A3 SK 103797 A SK103797 A SK 103797A SK 103797 A3 SK103797 A3 SK 103797A3
Authority
SK
Slovakia
Prior art keywords
hiv
compound
composition
mixture
azt
Prior art date
Application number
SK1037-97A
Other languages
English (en)
Slovak (sk)
Inventor
Jeffrey A Chodakewitz
Emilio A Emini
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of SK103797A3 publication Critical patent/SK103797A3/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK1037-97A 1995-02-01 1996-01-29 Mixture of compounds and pharmaceutical composition containing the same SK103797A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/382,113 US6689761B1 (en) 1995-02-01 1995-02-01 Combination therapy for HIV infection
PCT/US1996/001417 WO1996023509A1 (en) 1995-02-01 1996-01-29 Combination therapy for hiv infection using the hiv protease inhibitor indinavir and the reverse transcriptase inhibitor 3tc, optionally together with azt, ddi or ddc

Publications (1)

Publication Number Publication Date
SK103797A3 true SK103797A3 (en) 1998-02-04

Family

ID=23507574

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1037-97A SK103797A3 (en) 1995-02-01 1996-01-29 Mixture of compounds and pharmaceutical composition containing the same

Country Status (38)

Country Link
US (1) US6689761B1 (sh)
EP (1) EP0806957B1 (sh)
JP (1) JPH10513186A (sh)
KR (1) KR19980701856A (sh)
CN (1) CN1160081C (sh)
AR (1) AR002957A1 (sh)
AT (1) ATE243519T1 (sh)
AU (1) AU711176B2 (sh)
BR (1) BR9607714A (sh)
CA (1) CA2211973A1 (sh)
CO (1) CO4700430A1 (sh)
CZ (1) CZ244497A3 (sh)
DE (1) DE69628819T2 (sh)
DK (1) DK0806957T3 (sh)
DZ (1) DZ1988A1 (sh)
EA (1) EA000437B1 (sh)
EE (1) EE03514B1 (sh)
ES (1) ES2200052T3 (sh)
FI (1) FI973184A (sh)
HK (1) HK1004659A1 (sh)
HR (1) HRP960045B1 (sh)
HU (1) HUP9800810A3 (sh)
IL (1) IL116925A (sh)
IS (1) IS1970B (sh)
MX (1) MX9705916A (sh)
MY (1) MY121604A (sh)
NO (1) NO314568B1 (sh)
NZ (1) NZ302153A (sh)
PE (1) PE38397A1 (sh)
PL (1) PL182742B1 (sh)
PT (1) PT806957E (sh)
SA (1) SA96160669B1 (sh)
SK (1) SK103797A3 (sh)
TR (1) TR199700735T1 (sh)
TW (1) TW442291B (sh)
WO (1) WO1996023509A1 (sh)
YU (1) YU49417B (sh)
ZA (1) ZA96722B (sh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998008539A1 (en) * 1996-08-26 1998-03-05 Chiron Corporation Postinfection human immunodeficiency virus (hiv) vaccination therapy
AU6761198A (en) * 1998-03-17 1999-10-11 Julianna Lisziwiewicz Anti-hiv combination comprising hydroxyurea, ddi, and a protease inhibitor
US6875773B1 (en) 1998-05-29 2005-04-05 Ben M. Dunn Combination therapy for treatment of FIV infection
AU4219799A (en) * 1998-05-29 1999-12-13 University Of Florida Combination therapy for treatment of fiv infection
JP2003523721A (ja) 1998-12-31 2003-08-12 カイロン コーポレイション 抗原性hivc型ポリペプチドをコードするポリヌクレオチド、ポリペプチド、およびそれらの使用
WO2003004620A2 (en) 2001-07-05 2003-01-16 Chiron, Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
CA2583195A1 (en) * 2004-11-19 2006-05-26 Boehringer Ingelheim International Gmbh Method for treating hiv infection through co-administration of tipranavir and reverset
US7745455B2 (en) 2005-07-27 2010-06-29 Emil Toma Zalcitabine (ddC) boosted lamivudine (3TC) compositions for antiretroviral therapy
CA3047000A1 (en) * 2017-01-04 2018-07-12 Oyagen, Inc. Compounds, compositions, and methods for treating human immunodeficiency virus

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
US5254539A (en) * 1985-08-26 1993-10-19 U.S. Government, Dept. Of Health And Human Services, C/O National Institutes Of Health Method of treating HIV with 2',3'-dideoxyinosine
US5028595A (en) * 1987-09-18 1991-07-02 Hoffmann-La Roche Inc. Method for preventing AIDS in a subject or treating a subject infected with the AIDS virus
US5204466A (en) 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
IL100502A (en) 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
US5413999A (en) * 1991-11-08 1995-05-09 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
KR100311551B1 (ko) 1993-03-31 2001-12-28 폴락 돈나 엘. Aids 치료용 약제학적 배합물 중의 hiv 프로테아제 억제제
IL114208A0 (en) 1994-06-27 1995-10-31 Merck & Co Inc Combinations of compounds pharmaceutical compositions containing them and their use as hiv protease inhibitors

Also Published As

Publication number Publication date
IL116925A (en) 2000-07-26
SA96160669B1 (ar) 2006-07-30
FI973184A (fi) 1997-09-30
PE38397A1 (es) 1997-10-09
EP0806957A1 (en) 1997-11-19
HRP960045B1 (en) 2004-06-30
PL182742B1 (pl) 2002-02-28
JPH10513186A (ja) 1998-12-15
KR19980701856A (ko) 1998-06-25
CZ244497A3 (cs) 1998-01-14
CO4700430A1 (es) 1998-12-29
IS1970B (is) 2004-12-15
AU711176B2 (en) 1999-10-07
ES2200052T3 (es) 2004-03-01
BR9607714A (pt) 1998-01-13
FI973184A0 (fi) 1997-07-31
EE03514B1 (et) 2001-10-15
MX9705916A (es) 1997-10-31
NO314568B1 (no) 2003-04-14
HUP9800810A3 (en) 2001-05-28
CN1179722A (zh) 1998-04-22
DK0806957T3 (da) 2003-09-29
EA199700150A1 (ru) 1997-12-30
PT806957E (pt) 2003-10-31
EE9700165A (et) 1998-02-16
YU6396A (sh) 1999-06-15
NO973533L (no) 1997-10-01
TW442291B (en) 2001-06-23
ATE243519T1 (de) 2003-07-15
AU4774896A (en) 1996-08-21
DZ1988A1 (fr) 2002-07-20
HUP9800810A2 (hu) 1998-07-28
HRP960045A2 (en) 1997-10-31
CA2211973A1 (en) 1996-08-08
WO1996023509A1 (en) 1996-08-08
IL116925A0 (en) 1996-05-14
IS4533A (is) 1997-07-29
HK1004659A1 (en) 1998-12-04
MY121604A (en) 2006-02-28
NZ302153A (en) 1998-12-23
CN1160081C (zh) 2004-08-04
ZA96722B (en) 1996-08-26
DE69628819T2 (de) 2004-05-13
EP0806957B1 (en) 2003-06-25
YU49417B (sh) 2006-01-16
US6689761B1 (en) 2004-02-10
AR002957A1 (es) 1998-05-27
PL321660A1 (en) 1997-12-22
DE69628819D1 (de) 2003-07-31
EA000437B1 (ru) 1999-08-26
NO973533D0 (no) 1997-07-31
TR199700735T1 (xx) 1998-02-21

Similar Documents

Publication Publication Date Title
JP3133345B2 (ja) Hivに対して活性な連結環状ポリアミン
US5026716A (en) Method of treatment of anxiety and anxio-depressive disorders
SK103797A3 (en) Mixture of compounds and pharmaceutical composition containing the same
WO1999048371A1 (en) Novel hiv integrase inhibitors and hiv therapy based on drug combinations including integrase inhibitors
JPH0232093A (ja) 抗レトロウィルスジフルオロ化ヌクレオシド類
US6180634B1 (en) Combination therapy for the treatment of AIDS
SK163996A3 (en) Combinated medicament and pharmaceutical composition containing its, used to therapy of hiv infection
EP1044000B1 (en) Combination therapy for the treatment of aids
AU764265B2 (en) Viral treatment
CA2197207C (en) Hiv protease inhibitor combination
CZ20001752A3 (cs) Farmaceutické prostředky obsahující kombinaci pro léčbu AIDS